Company / EPS (Basic)
Imunon, Inc. EPS (Basic) History
FY2022-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$5.03
FY2023
5-year range
-$5.03 / -$3.83
FY2022-FY2023
Trend
-31.3%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-5.03 in FY2023.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, eps (basic) decreased 31.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2023 | -$5.03 | -31.3% |
| FY2022 | -$3.83 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2015 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026